Los puntos clave no están disponibles para este artículo en este momento.
An array of well-heeled new players has dramatically reshaped how wealthy countries tackle infectious diseases of the poor. But increasingly, these ambitious efforts are confronting their own limitations
Jon Cohen (Thu,) studied this question.